HL-009 Liposomal Gel

· HanAll BioPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HL-009 Liposomal Gel, covering 2025-04-22 to 2025-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis [Phase 2]